Pacific Heights Asset Management LLC Atara Biotherapeutics, Inc. Transaction History

Pacific Heights Asset Management LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Jul 23, 2021	BUY	$12.89 - $16.58 $1.29 Million - $1.66 Million	100,000 Added 23.53%	525,000 $8.16 Million
Q1 2021 Apr 30, 2021	BUY	$14.0 - $20.72 $2.1 Million - $3.11 Million	150,000 Added 54.55%	425,000 $6.1 Million
Q2 2020 Aug 13, 2020	BUY	$7.53 - $14.93 $165,660 - $328,460	22,000 Added 8.7%	275,000 $4.01 Million
Q1 2020 Apr 29, 2020	BUY	$5.69 - $17.78 $443,820 - $1.39 Million	78,000 Added 44.57%	253,000 $2.84 Million
Q1 2019 Apr 25, 2019	BUY	$28.4 - $41.74 $1.42 Million - $2.09 Million	50,000 Added 40.0%	175,000 $6.96 Million

Q1 2018 May 08, 2018	BUY	$18.0 - $48.35 $1.8 Million - $4.84 Million	100,000 Added 400.0%	125,000 $4.88 Million
Q4 2017 Feb 07, 2018	BUY	$13.2 - $18.1 $330,000 - $452,500	25,000	25,000 $453,000

85M

18.4K

51.3K

Ticker ATRA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 94,362,304
Market Cap $728M
Description
Atara Biotherapeutics, Inc., an off-the-shelf T-cell immunotherapy company, develops treatments for patients with cancer, autoimmune, and viral diseases in the United States. It is developing tabelecleucel, a T-cell immunotherapy that is Phase 3 clinical trials for the treatment of epstein-barr virus (EBV) driven post-transplant lymphoproliferat...

Get notified when there are updates to the investment portfolio of Pacific Heights Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Pacific Heights Asset Management LLC with notifications on news.